As of 2025-10-19, the Intrinsic Value of Pangenomic Health Inc (NARA.CN) is -0.66 CAD. This NARA.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.50 CAD, the upside of Pangenomic Health Inc is -144.74%.
Based on its market price of 1.50 CAD and our intrinsic valuation, Pangenomic Health Inc (NARA.CN) is overvalued by 144.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.66 - -0.66 | -0.66 | -144.74% |
| DDM - Stable | (0.31) - (0.57) | (0.44) | -129.7% |
| DDM - Multi | (0.49) - (0.72) | (0.58) | -139.2% |
| Market Cap (mil) | 20.85 |
| Beta | 2.59 |
| Outstanding shares (mil) | 13.90 |
| Enterprise Value (mil) | 31.77 |
| Market risk premium | 5.10% |
| Cost of Equity | 20.54% |
| Cost of Debt | 5.00% |
| WACC | 12.12% |